What are the new drugs for gastric cancer treatment?
Disease description:
When I was young, due to work-related reasons, my eating habits were irregular, and I often consumed alcohol, leading to the development of stomach cancer. Are there any new medications available for treatment at this time?
Doctor's answer (1)
Dr. Shen Yonghua
The new drugs for gastric cancer treatment mainly include targeted therapies and immune checkpoint inhibitors. In terms of targeted therapies, there is zolbetuximab (Zolbetuximab), which targets Claudin 18.2, and CT041 autologous CAR-T cell therapy, both of which have demonstrated promising anti-tumor effects in clinical trials. Regarding immune checkpoint inhibitors, the novel bispecific antibody Cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody globally, has been included in the 2024 CSCO guidelines for first-line treatment of advanced gastric cancer, significantly prolonging patient survival. Additionally, other new PD-1/VEGF bispecific antibodies such as Ivonescimab are also under investigation, providing new treatment options for gastric cancer. These new drugs offer greater treatment hope and survival opportunities for patients with gastric cancer.
